featured
Sorafenib With or Without Everolimus in HCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sorafenib With or Without Everolimus in Patients With Advanced Hepatocellular Carcinoma (HCC): A Randomized Multicenter, Multinational Phase II Trial (SAKK 77/08 and SASL 29)
Ann. Oncol 2016 Feb 15;[EPub Ahead of Print], D Koeberle, JF Dufour, G Demeter, Q Li, K Ribi, P Samaras, P Saletti, AD Roth, D Horber, M Buehlmann, AD Wagner, M Montemurro, G Lakatos, J Feilchenfeldt, M Peck-Radosavljevic, D Rauch, B Tschanz, G BodokyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.